Emergent BioSolutions | EBS - 债务利息支出



金融业
股票价格
USD
资产
USD 1.82B
现金及等价物
USD 111.7M
销售成本
USD 381.2M
流动资产
USD 679.5M
流动负债
USD 651.3M
债务
USD 903.2M
股息收益率
0
EBIT
USD -148.1M
EBITDA
USD -113.5M
员工
1.6K
EPS每股收益
USD -0.77
股本和储备
USD 649.3M
销售毛利
USD 10M
债务利息支出
USD 17.9M
贷款资金
USD 446.5M
市值
USD 417.6M
净收入
USD -261.3M
营业费用
USD 555.9M
营业利润
USD -218M
普通股股本
USD 100K
PE价格收益
14.4
税前利润
USD -130.8M
销售收入
USD 276.6M
销售和管理费用
USD 182.8M
股票
USD 328.9M
贸易债权人
USD 112.2M
应收帐款人
USD 290.1M


债务利息支出 更改 日
Acadia Pharmaceuticals USD 0 4.12M 2024-09
Akebia Therapeutics 362.52M 357.69M 2026-03
ALKERMES USD 20.89M 8.62M 2026-03
Alnylam Pharmaceuticals USD 69.29M 60.05M 2026-03
Amarin USD 3K 5K 2024-12
ANI Pharmaceuticals USD 4.41M 316K 2025-12
BioMarin Pharmaceutical USD 14.96M 12.18M 2026-03
Coherus Biosciences USD 2.25M 76K 2025-12
Exelixis USD 23.4M 3.9M 2023-09
Glaxosmithkline GBP 177.95M 6.05M 2025-09
Heron Therapeutics USD 600K 100K 2024-12
Ionis Pharmaceuticals USD 17M 1000K 2026-03
Ironwood Pharmaceuticals USD 8.74M 506K 2024-12
Lexicon Pharmaceuticals USD 2.03M 124K 2025-12
Lonza CHF 84M 14M 2025-06
Merck USD 479M 67M 2026-03
Moderna USD 11.49B 36B 2026-03
Myriad Genetics USD 4.4M 600K 2025-12
Nektar Therapeutics USD 9.77M 3.75M 2025-12
Neurocrine Biosciences USD 1.1M 0 2024-03
Pacira USD 3.7M 193K 2026-03
Pfizer USD 671M 40M 2026-03
PTC Therapeutics USD 2.87B 2.82B 2026-03
Sanofi EUR 178M 203M 2026-03
Sarepta Therapeutics USD 20.84M 13.28M 2025-12
United Therapeutics USD 3.1M 100K 2025-12
Vanda Pharmaceuticals -1.37B 1.97B 2025-12
Xoma USD 3.4M 150K 2024-06